Contravisory Investment Management, Inc. Biomarin Pharmaceutical Inc Transaction History

Contravisory Investment Management, Inc.

  • $453 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 09, 2019
SELL
$80.35 - $93.9 $3.71 Million - $4.33 Million
-46,134 Closed
0 $0
Q1 2019

Apr 08, 2019
SELL
$84.2 - $98.62 $42,100 - $49,310
-500 Reduced 1.07%
46,134 $4.1 Million
Q4 2018

Jan 14, 2019
BUY
$80.14 - $106.07 $3.74 Million - $4.95 Million
46,634 New
46,634 $3.97 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Contravisory Investment Management, Inc. Portfolio

Follow Contravisory Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email